Current Report Filing (8-k)
August 02 2019 - 1:09PM
Edgar (US Regulatory)
0000816956
false
0000816956
2019-08-01
2019-08-02
0000816956
2019-08-02
2019-08-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________
FORM
8-K
_________________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
August 2, 2019
_______________________________
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
_______________________________
|
New York
|
0-16093
|
16-0977505
|
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
|
of Incorporation)
|
File Number)
|
Identification No.)
|
525 French Road
Utica
,
New York
13502
(Address of Principal
Executive Offices) (Zip Code)
315
-
797-8375
(Registrant’s
telephone number, including area code)
N/A
(Former name or former address,
if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.01 par value
|
CNMD
|
NASDAQ
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On August 2, 2019, CONMED Corporation announced
it will be paying a quarterly cash dividend of $0.20 per share on October 7, 2019 to all shareholders of record as of September
13, 2019.
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: August 2, 2019
|
CONMED CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Todd W. Garner
|
|
|
Name:
|
Todd W. Garner
|
|
|
Title:
|
Executive Vice President-
|
|
|
|
Chief Financial Officer
|
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024
